Hospital devices Medical devices

The online source of technology & product information for life scientist & bioentrepreneurs

E-newsflash: Details

Genentech considers Roche offer too low

Issue date: 20 August 2008

The special committee set up by Genentech to evaluate the offer from Roche to buy for $89.00 a share the shares in Genentech that Roche does not already own has unanimously concluded that Roche's proposal substantially undervalues the company. Therefore, the special committee does not support the proposal. However, the special committee would consider a proposal that recognizes the value of the company and reflects

 

Opens external link in new windowMore info on Genetech reaction to Roche proposal


< - Back to list
Barco at ECR - Expo B, stand 201

Sponsored links: